Hepatic Impairment Completed Phase 1 Trials for Telotristat ethyl (DB12095)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02683577Study to Evaluate a Dose of Telotristat Etiprate in Male and Female With Mild, Moderate and Severe Hepatic Insufficiency and Matched Healthy SubjectsBasic Science
NCT03423446Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic ImpairmentTreatment